Literature Screening
Conduct title, abstract, and full-text screening using a Rayyan-inspired workflow with conflict resolution and multi-reviewer collaboration.
Β§ Available Now
Conduct systematic reviews, meta-analyses, and omics evidence synthesis in one AI-assisted platform built for researchers, clinicians, and bioinformaticians.

3
Review Stages
10+
Statistical Analyses
PRISMA
2020 Ready
Integrates with the sources and standards you already use
Β§ Features
From import to publication-ready output in one platform - no stitching tools together.
Conduct title, abstract, and full-text screening using a Rayyan-inspired workflow with conflict resolution and multi-reviewer collaboration.
Pool effect sizes and quantify heterogeneity in minutes, using fixed and random effects models with publication-ready forest and funnel plots.
Synthesize evidence across populations and studies with GWAS variant aggregation, weighted gene-level RNA-seq summaries, and chromosome-level Manhattan plots.
Cut screening time by surfacing the most relevant studies first, with AI-powered relevance scoring against your research question.
Stay reporting-compliant with zero manual bookkeeping, using automated PRISMA flow diagrams that track counts at every stage.
Keep review teams in sync with role-based access, dual-reviewer screening, conflict detection, and a full audit trail.
Β§ See EvidenceFlow in Action
Every screen is designed around real systematic review workflows.

Rayyan-style abstract viewer with AI relevance scores, include/exclude controls, conflict detection, and stage-by-stage progress.

Forest plots, funnel plots, PRISMA flow diagrams, and omics Manhattan plots - all generated from your extracted study data.
Β§ Workflow
A structured pipeline that mirrors established systematic review methodology.
Upload PubMed XML, RIS, BibTeX, or CSV. Automatic duplicate detection removes redundant records.
AI pre-scores relevance. Reviewers work through title, abstract, and full-text stages with conflict tracking.
Structured clinical and omics forms capture effect sizes, genes, variants, populations, and risk of bias.
Fixed and random effects pooling, heterogeneity statistics, and GWAS / RNA-seq omics synthesis.
Export publication-ready PDF reports, PRISMA diagrams, forest plots, and JSON data packages.
Β§ Who Itβs For
Whether youβre running a single review or coordinating a department, EvidenceFlow fits the workflow.
Conduct PRISMA-compliant systematic reviews without switching between screening, extraction, and reporting tools.
Integrate GWAS, RNA-seq, and genomic datasets into your evidence synthesis alongside clinical literature.
Complete dissertations and evidence syntheses faster with AI-assisted screening and structured data extraction.
Run collaborative evidence reviews across departments with role-based access and a shared audit trail.
EvidenceFlow is free and transparent - because good research infrastructure should be shared, not siloed.
All statistical methods are documented and auditable. Reproducible analyses with full parameter history.
Export full data packages JSON, PDFs, and plots so every review step can be independently verified.
Your data is never locked in. Every project exports as CSV, JSON, and PDF, ready for reuse elsewhere.
Import from PubMed, RIS, and BibTeX, and generate PRISMA 2020-compliant flow diagrams out of the box.
Β§ FAQ
EvidenceFlow is a free, AI-powered systematic review platform that automates literature screening, data extraction, PRISMA reporting, and meta-analysis for researchers and clinicians.
Yes. EvidenceFlow is completely free. Create an account and start your first systematic review immediately with no subscription required.
EvidenceFlow uses local large language models (via Ollama) to screen studies against your PICO criteria and inclusion/exclusion criteria. It provides a decision (include/exclude/maybe), confidence score, and a one-sentence reason for each study.
EvidenceFlow combines the collaborative screening features of Rayyan with the meta-analysis capabilities of RevMan, and adds AI automation for screening and extraction, all in a single free platform.
Yes. EvidenceFlow automatically generates a PRISMA 2020 flow diagram based on your screening decisions and study counts, which can be exported as part of your PDF or Word report.
EvidenceFlow supports RIS, BibTeX, CSV, and direct PubMed search import. You can also upload full-text PDFs for full-text screening.
No, EvidenceFlow is not open source. It is completely free to use, and every project you create exports as CSV, JSON, or PDF, so your data is never locked in.
Yes. EvidenceFlow supports multi-reviewer projects with role-based access, dual-reviewer screening, conflict detection, and an audit trail of every decision.
EvidenceFlow's meta-analysis engine supports fixed and random effects models with pooled effect sizes, IΒ², Cochran's Q, and TauΒ² heterogeneity statistics, visualized as forest and funnel plots.
Yes. PRISMA 2020 flow diagrams are generated automatically from your screening decisions and can be exported as part of your PDF or Word report.
Yes. You can export your PRISMA flow diagram, PDF report, Word document, or full CSV/JSON data package at any point in your project.
Yes. Your projects and study data are private to your account and visible only to reviewers you explicitly invite to a project.
EvidenceFlow's AI screening runs on local large language models via Ollama, so no external API keys are required and your data never leaves the screening environment.
EvidenceFlow is designed for clinical researchers, bioinformaticians, medical students, and universities running systematic reviews, meta-analyses, or omics evidence synthesis.
Yes. EvidenceFlow integrates GWAS variant aggregation, RNA-seq gene-level summaries, and Manhattan plot visualization alongside your systematic review workflow.
Create an account, import your references, and start AI-assisted screening with no configuration needed. EvidenceFlow is completely free.